{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T09:32:40Z","timestamp":1789464760830,"version":"build-2803163510"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T00:00:00Z","timestamp":1676332800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T00:00:00Z","timestamp":1676332800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"crossref","award":["MOST 110-2320-B-039-037 and MOST 111-2314-B-894-001"],"award-info":[{"award-number":["MOST 110-2320-B-039-037 and MOST 111-2314-B-894-001"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004391","name":"China Medical University Hospital, Taiwan","doi-asserted-by":"crossref","award":["DMR-108-217, DMR-109-245"],"award-info":[{"award-number":["DMR-108-217, DMR-109-245"]}],"id":[{"id":"10.13039\/501100004391","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1007\/s11064-023-03884-1","type":"journal-article","created":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T09:49:30Z","timestamp":1676368170000},"page":"2066-2076","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Determination of D-serine and D-alanine Tissue Levels in the Prefrontal Cortex and Hippocampus of Rats After a Single Dose of Sodium Benzoate, a D-Amino Acid Oxidase Inhibitor, with Potential Antipsychotic and Antidepressant Properties"],"prefix":"10.1007","volume":"48","author":[{"given":"Chih-Chia","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I-Hua","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Ting","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsien-Yuan","family":"Lane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,14]]},"reference":[{"issue":"3","key":"3884_CR1","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1017\/neu.2015.59","volume":"28","author":"K Hashimoto","year":"2016","unstructured":"Hashimoto K, Yoshida T, Ishikawa M, Fujita Y, Niitsu T, Nakazato M, Watanabe H, Sasaki T, Shiina A, Hashimoto T, Kanahara N, Hasegawa T, Enohara M, Kimura A, Iyo M (2016) Increased serum levels of serine enantiomers in patients with depression. Acta neuropsychiatrica 28(3):173\u2013178. https:\/\/doi.org\/10.1017\/neu.2015.59","journal-title":"Acta neuropsychiatrica"},{"key":"3884_CR2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2017.16","author":"JW Murrough","year":"2017","unstructured":"Murrough JW, Abdallah CG, Mathew SJ (2017) Targeting glutamate signalling in depression: progress and prospects. Nat reviews Drug discovery press. https:\/\/doi.org\/10.1038\/nrd.2017.16","journal-title":"Nat reviews Drug discovery press"},{"key":"3884_CR3","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.pnpbp.2015.02.015","volume":"64","author":"L Deutschenbaur","year":"2016","unstructured":"Deutschenbaur L, Beck J, Kiyhankhadiv A, Muhlhauser M, Borgwardt S, Walter M, Hasler G, Sollberger D, Lang UE (2016) Role of calcium, glutamate and NMDA in major depression and therapeutic application. Prog Neuro-psychopharmacol Biol Psychiatry 64:325\u2013333. https:\/\/doi.org\/10.1016\/j.pnpbp.2015.02.015","journal-title":"Prog Neuro-psychopharmacol Biol Psychiatry"},{"issue":"1\u20132","key":"3884_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/BF03402101","volume":"9","author":"A Sawa","year":"2003","unstructured":"Sawa A, Snyder SH (2003) Schizophrenia: neural mechanisms for novel therapies. Mol Med (Cambridge Mass) 9(1\u20132):3\u20139","journal-title":"Mol Med (Cambridge Mass)"},{"issue":"10","key":"3884_CR5","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1016\/j.jpsychires.2013.06.013","volume":"47","author":"F Errico","year":"2013","unstructured":"Errico F, Napolitano F, Squillace M, Vitucci D, Blasi G, de Bartolomeis A, Bertolino A, D\u2019Aniello A, Usiello A (2013) Decreased levels of D-aspartate and NMDA in the prefrontal cortex and striatum of patients with schizophrenia. J Psychiatr Res 47(10):1432\u20131437. https:\/\/doi.org\/10.1016\/j.jpsychires.2013.06.013","journal-title":"J Psychiatr Res"},{"issue":"5","key":"3884_CR6","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1093\/schbul\/sbs100","volume":"38","author":"DC Javitt","year":"2012","unstructured":"Javitt DC (2012) Twenty-five years of glutamate in schizophrenia: are we there yet? Schizophr Bull 38(5):911\u2013913. https:\/\/doi.org\/10.1093\/schbul\/sbs100","journal-title":"Schizophr Bull"},{"issue":"1","key":"3884_CR7","first-page":"12","volume":"9","author":"DC Javitt","year":"1987","unstructured":"Javitt DC (1987) Negative schizophrenic symptomatology and the PCP (phencyclidine) model of schizophrenia. Hillside J Clin psychiatry 9(1):12\u201335","journal-title":"Hillside J Clin psychiatry"},{"issue":"10","key":"3884_CR8","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1176\/ajp.148.10.1301","volume":"148","author":"DC Javitt","year":"1991","unstructured":"Javitt DC, Zukin SR (1991) Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148(10):1301\u20131308. https:\/\/doi.org\/10.1176\/ajp.148.10.1301","journal-title":"Am J Psychiatry"},{"issue":"3","key":"3884_CR9","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1001\/archpsyc.1994.03950030035004","volume":"51","author":"JH Krystal","year":"1994","unstructured":"Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD, Heninger GR, Bowers MB Jr, Charney DS (1994) Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry 51(3):199\u2013214","journal-title":"Arch Gen Psychiatry"},{"issue":"6","key":"3884_CR10","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1097\/00001756-199504190-00011","volume":"6","author":"AC Lahti","year":"1995","unstructured":"Lahti AC, Holcomb HH, Medoff DR, Tamminga CA (1995) Ketamine activates psychosis and alters limbic blood flow in schizophrenia. NeuroReport 6(6):869\u2013872","journal-title":"NeuroReport"},{"issue":"2","key":"3884_CR11","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0006-3223(03)00707-8","volume":"55","author":"U Heresco-Levy","year":"2004","unstructured":"Heresco-Levy U, Ermilov M, Lichtenberg P, Bar G, Javitt DC (2004) High-dose glycine added to olanzapine and risperidone for the treatment of schizophrenia. Biol Psychiatry 55(2):165\u2013171","journal-title":"Biol Psychiatry"},{"issue":"11","key":"3884_CR12","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1001\/archpsyc.62.11.1196","volume":"62","author":"HY Lane","year":"2005","unstructured":"Lane HY, Chang YC, Liu YC, Chiu CC, Tsai GE (2005) Sarcosine or D-serine add-on treatment for acute exacerbation of schizophrenia: a randomized, double-blind, placebo-controlled study. Arch Gen Psychiatry 62(11):1196\u20131204. https:\/\/doi.org\/10.1001\/archpsyc.62.11.1196","journal-title":"Arch Gen Psychiatry"},{"issue":"6","key":"3884_CR13","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.biopsych.2006.04.005","volume":"60","author":"HY Lane","year":"2006","unstructured":"Lane HY, Huang CL, Wu PL, Liu YC, Chang YC, Lin PY, Chen PW, Tsai G (2006) Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to clozapine for the treatment of schizophrenia. Biol Psychiatry 60(6):645\u2013649. https:\/\/doi.org\/10.1016\/j.biopsych.2006.04.005","journal-title":"Biol Psychiatry"},{"issue":"1","key":"3884_CR14","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.biopsych.2007.04.038","volume":"63","author":"HY Lane","year":"2008","unstructured":"Lane HY, Liu YC, Huang CL, Chang YC, Liau CH, Perng CH, Tsai GE (2008) Sarcosine (N-methylglycine) treatment for acute schizophrenia: a randomized, double-blind study. Biol Psychiatry 63(1):9\u201312. https:\/\/doi.org\/10.1016\/j.biopsych.2007.04.038","journal-title":"Biol Psychiatry"},{"issue":"3","key":"3884_CR15","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.biopsych.2005.06.032","volume":"59","author":"GE Tsai","year":"2006","unstructured":"Tsai GE, Yang P, Chang YC, Chong MY (2006) D-alanine added to antipsychotics for the treatment of schizophrenia. Biol Psychiatry 59(3):230\u2013234. https:\/\/doi.org\/10.1016\/j.biopsych.2005.06.032","journal-title":"Biol Psychiatry"},{"issue":"10","key":"3884_CR16","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1016\/j.biopsych.2013.02.020","volume":"74","author":"CC Huang","year":"2013","unstructured":"Huang CC, Wei IH, Huang CL, Chen KT, Tsai MH, Tsai P, Tun R, Huang KH, Chang YC, Lane HY, Tsai GE (2013) Inhibition of glycine transporter-I as a novel mechanism for the treatment of depression. Biol Psychiatry 74(10):734\u2013741. https:\/\/doi.org\/10.1016\/j.biopsych.2013.02.020","journal-title":"Biol Psychiatry"},{"key":"3884_CR17","doi-asserted-by":"publisher","first-page":"162","DOI":"10.3389\/fnbeh.2015.00162","volume":"9","author":"KT Chen","year":"2015","unstructured":"Chen KT, Tsai MH, Wu CH, Jou MJ, Wei IH, Huang CC (2015) AMPA Receptor-mTOR activation is required for the antidepressant-like Effects of Sarcosine during the forced swim test in rats: insertion of AMPA receptor may play a role. Front Behav Neurosci 9:162. https:\/\/doi.org\/10.3389\/fnbeh.2015.00162","journal-title":"Front Behav Neurosci"},{"issue":"49","key":"3884_CR18","doi-asserted-by":"publisher","first-page":"10792","DOI":"10.1021\/acs.jafc.7b04217","volume":"65","author":"IH Wei","year":"2017","unstructured":"Wei IH, Chen KT, Tsai MH, Wu CH, Lane HY, Huang CC (2017) Acute amino acid d-Serine administration, similar to ketamine, produces antidepressant-like Effects through identical mechanisms. J Agric Food Chem 65(49):10792\u201310803. https:\/\/doi.org\/10.1021\/acs.jafc.7b04217","journal-title":"J Agric Food Chem"},{"issue":"4","key":"3884_CR19","doi-asserted-by":"publisher","first-page":"e9","DOI":"10.1016\/j.biopsych.2011.10.034","volume":"71","author":"C-H Lai","year":"2012","unstructured":"Lai C-H, Lane H-Y, Tsai GE (2012) Clinical and cerebral volumetric effects of sodium benzoate, a D-amino acid oxidase inhibitor, in a drug-naive patient with major depression. Biol Psychiatry 71(4):e9\u2013e10","journal-title":"Biol Psychiatry"},{"issue":"4","key":"3884_CR20","first-page":"609","volume":"47","author":"D Strzelecki","year":"2013","unstructured":"Strzelecki D, Kropiwnicki P, Rabe-Jab\u0142o\u0144ska J (2013) [Augmentation of antipsychotics with glycine may ameliorate depressive and extrapyramidal symptoms in schizophrenic patients\u2013a preliminary 10-week open-label study]. Psychiatr Pol 47(4):609\u2013620","journal-title":"Psychiatr Pol"},{"issue":"1\u20133","key":"3884_CR21","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.schres.2010.05.012","volume":"121","author":"JT Kantrowitz","year":"2010","unstructured":"Kantrowitz JT, Malhotra AK, Cornblatt B, Silipo G, Balla A, Suckow RF, D\u2019Souza C, Saksa J, Woods SW, Javitt DC (2010) High dose D-serine in the treatment of schizophrenia. Schizophr Res 121(1\u20133):125\u2013130. https:\/\/doi.org\/10.1016\/j.schres.2010.05.012","journal-title":"Schizophr Res"},{"issue":"2","key":"3884_CR22","first-page":"269","volume":"77","author":"CE Ganote","year":"1974","unstructured":"Ganote CE, Peterson DR, Carone FA (1974) The nature of D-serine\u2013induced nephrotoxicity. Am J Pathol 77(2):269\u2013282","journal-title":"Am J Pathol"},{"issue":"1","key":"3884_CR23","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.tox.2004.08.008","volume":"207","author":"RE Williams","year":"2005","unstructured":"Williams RE, Lock EA (2005) Sodium benzoate attenuates D-serine induced nephrotoxicity in the rat. Toxicology 207(1):35\u201348. https:\/\/doi.org\/10.1016\/j.tox.2004.08.008","journal-title":"Toxicology"},{"issue":"2","key":"3884_CR24","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.juro.2010.09.077","volume":"185","author":"F Jentzmik","year":"2011","unstructured":"Jentzmik F, Stephan C, Lein M, Miller K, Kamlage B, Bethan B, Kristiansen G, Jung K (2011) Sarcosine in prostate cancer tissue is not a differential metabolite for prostate cancer aggressiveness and biochemical progression. J Urol 185(2):706\u2013711. https:\/\/doi.org\/10.1016\/j.juro.2010.09.077","journal-title":"J Urol"},{"key":"3884_CR25","doi-asserted-by":"publisher","unstructured":"Walczak-Nowicka \u0141J, Herbet M (2022) Sodium Benzoate-Harmfulness and potential use in therapies for Disorders related to the nervous system: a review. Nutrients 14(7). https:\/\/doi.org\/10.3390\/nu14071497","DOI":"10.3390\/nu14071497"},{"key":"3884_CR26","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3389\/fpsyt.2019.00025","volume":"10","author":"MB MacKay","year":"2019","unstructured":"MacKay MB, Kravtsenyuk M, Thomas R, Mitchell ND, Dursun SM, Baker GB (2019) D-Serine: potential therapeutic Agent and\/or biomarker in Schizophrenia and Depression? Front Psychiatry 10:25. https:\/\/doi.org\/10.3389\/fpsyt.2019.00025","journal-title":"Front Psychiatry"},{"key":"3884_CR27","doi-asserted-by":"publisher","first-page":"742058","DOI":"10.3389\/fpsyt.2021.742058","volume":"12","author":"JC Pei","year":"2021","unstructured":"Pei JC, Luo DZ, Gau SS, Chang CY, Lai WS (2021) Directly and indirectly targeting the Glycine Modulatory Site to modulate NMDA receptor function to address Unmet Medical needs of patients with Schizophrenia. Front Psychiatry 12:742058. https:\/\/doi.org\/10.3389\/fpsyt.2021.742058","journal-title":"Front Psychiatry"},{"issue":"10","key":"3884_CR28","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1080\/17460441.2018.1524459","volume":"13","author":"B Szil\u00e1gyi","year":"2018","unstructured":"Szil\u00e1gyi B, Ferenczy GG, Keser\u0171 GM (2018) Drug discovery strategies and the preclinical development of D-amino-acid oxidase inhibitors as antipsychotic therapies. Expert Opin Drug Discov 13(10):973\u2013982. https:\/\/doi.org\/10.1080\/17460441.2018.1524459","journal-title":"Expert Opin Drug Discov"},{"issue":"6","key":"3884_CR29","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1038\/npp.2015.319","volume":"41","author":"C Rojas","year":"2016","unstructured":"Rojas C, Alt J, Ator NA, Thomas AG, Wu Y, Hin N, Wozniak K, Ferraris D, Rais R, Tsukamoto T, Slusher BS (2016) D-Amino-acid oxidase inhibition increases D-Serine plasma levels in mouse but not in Monkey or Dog. Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology 41(6):1610\u20131619. https:\/\/doi.org\/10.1038\/npp.2015.319","journal-title":"Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology"},{"issue":"3","key":"3884_CR30","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1017\/neu.2015.1","volume":"27","author":"A Matsuura","year":"2015","unstructured":"Matsuura A, Fujita Y, Iyo M, Hashimoto K (2015) Effects of sodium benzoate on pre-pulse inhibition deficits and hyperlocomotion in mice after administration of phencyclidine. Acta neuropsychiatrica 27(3):159\u2013167. https:\/\/doi.org\/10.1017\/neu.2015.1","journal-title":"Acta neuropsychiatrica"},{"issue":"1\u20132","key":"3884_CR31","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1007\/s11064-016-1838-8","volume":"41","author":"H Sershen","year":"2016","unstructured":"Sershen H, Hashim A, Dunlop DS, Suckow RF, Cooper TB, Javitt DC (2016) Modulating NMDA receptor function with D-Amino acid oxidase inhibitors: understanding functional activity in PCP-Treated mouse model. Neurochem Res 41(1\u20132):398\u2013408. https:\/\/doi.org\/10.1007\/s11064-016-1838-8","journal-title":"Neurochem Res"},{"issue":"12","key":"3884_CR32","doi-asserted-by":"publisher","first-page":"3357","DOI":"10.1021\/jm800200u","volume":"51","author":"D Ferraris","year":"2008","unstructured":"Ferraris D, Duvall B, Ko YS, Thomas AG, Rojas C, Majer P, Hashimoto K, Tsukamoto T (2008) Synthesis and biological evaluation of D-amino acid oxidase inhibitors. J Med Chem 51(12):3357\u20133359. https:\/\/doi.org\/10.1021\/jm800200u","journal-title":"J Med Chem"},{"key":"3884_CR33","doi-asserted-by":"publisher","unstructured":"Strick CA, Li C, Scott L, Harvey B, Haj\u00f3s M, Steyn SJ, Piotrowski MA, James LC, Downs JT, Rago B, Becker SL, El-Kattan A, Xu Y, Ganong AH, Tingley FD 3rd, Ramirez AD, Seymour PA, Guanowsky V, Majchrzak MJ, Fox CB, Schmidt CJ, Duplantier AJ (2011) Modulation of NMDA receptor function by inhibition of D-amino acid oxidase in rodent brain. Neuropharmacology 61(5\u20136):1001\u20131015. https:\/\/doi.org\/10.1016\/j.neuropharm.2011.06.029","DOI":"10.1016\/j.neuropharm.2011.06.029"},{"issue":"3\u20134","key":"3884_CR34","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/0305-0491(93)90113-j","volume":"105","author":"A D\u2019Aniello","year":"1993","unstructured":"D\u2019Aniello A, Vetere A, Petrucelli L (1993) Further study on the specificity of D-amino acid oxidase and D-aspartate oxidase and time course for complete oxidation of D-amino acids. Comp Biochem Physiol B Comp Biochem 105(3\u20134):731\u2013734. https:\/\/doi.org\/10.1016\/0305-0491(93)90113-j","journal-title":"Comp Biochem Physiol B Comp Biochem"},{"issue":"1","key":"3884_CR35","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/s0378-4347(01)00131-1","volume":"757","author":"A Morikawa","year":"2001","unstructured":"Morikawa A, Hamase K, Inoue T, Konno R, Niwa A, Zaitsu K (2001) Determination of free D-aspartic acid, D-serine and D-alanine in the brain of mutant mice lacking D-amino acid oxidase activity. J Chromatogr B Biomedical Sci Appl 757(1):119\u2013125. https:\/\/doi.org\/10.1016\/s0378-4347(01)00131-1","journal-title":"J Chromatogr B Biomedical Sci Appl"},{"issue":"1","key":"3884_CR36","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/0167-4838(92)90418-d","volume":"1120","author":"L Pollegioni","year":"1992","unstructured":"Pollegioni L, Falbo A, Pilone MS (1992) Specificity and kinetics of Rhodotorula gracilis D-amino acid oxidase. Biochim Biophys Acta 1120(1):11\u201316. https:\/\/doi.org\/10.1016\/0167-4838(92)90418-d","journal-title":"Biochim Biophys Acta"},{"issue":"11","key":"3884_CR37","doi-asserted-by":"publisher","first-page":"2832","DOI":"10.1021\/acschemneuro.8b00229","volume":"9","author":"M Popiolek","year":"2018","unstructured":"Popiolek M, Tierney B, Steyn SJ, DeVivo M (2018) Lack of Effect of Sodium Benzoate at reported clinical therapeutic concentration on d-Alanine metabolism in Dogs. ACS Chem Neurosci 9(11):2832\u20132837. https:\/\/doi.org\/10.1021\/acschemneuro.8b00229","journal-title":"ACS Chem Neurosci"},{"issue":"9","key":"3884_CR38","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1248\/bpb.28.1578","volume":"28","author":"K Hamase","year":"2005","unstructured":"Hamase K, Konno R, Morikawa A, Zaitsu K (2005) Sensitive determination of D-amino acids in mammals and the effect of D-amino-acid oxidase activity on their amounts. Biol Pharm Bull 28(9):1578\u20131584. https:\/\/doi.org\/10.1248\/bpb.28.1578","journal-title":"Biol Pharm Bull"},{"issue":"29","key":"3884_CR39","doi-asserted-by":"publisher","first-page":"3184","DOI":"10.1016\/j.jchromb.2010.08.024","volume":"879","author":"Y Miyoshi","year":"2011","unstructured":"Miyoshi Y, Hamase K, Okamura T, Konno R, Kasai N, Tojo Y, Zaitsu K (2011) Simultaneous two-dimensional HPLC determination of free D-serine and D-alanine in the brain and periphery of mutant rats lacking D-amino-acid oxidase. J Chromatogr B 879(29):3184\u20133189. Analytical technologies in the biomedical and life sciences10.1016\/j.jchromb.2010.08.024","journal-title":"J Chromatogr B"},{"key":"3884_CR40","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.pnpbp.2019.02.001","volume":"92","author":"B Peyrovian","year":"2019","unstructured":"Peyrovian B, Rosenblat JD, Pan Z, Iacobucci M, Brietzke E, McIntyre RS (2019) The glycine site of NMDA receptors: a target for cognitive enhancement in psychiatric disorders. Prog Neuro-psychopharmacol Biol Psychiatry 92:387\u2013404. https:\/\/doi.org\/10.1016\/j.pnpbp.2019.02.001","journal-title":"Prog Neuro-psychopharmacol Biol Psychiatry"},{"issue":"21","key":"3884_CR41","doi-asserted-by":"publisher","first-page":"9604","DOI":"10.1523\/jneurosci.22-21-09604.2002","volume":"22","author":"RJ Ralph-Williams","year":"2002","unstructured":"Ralph-Williams RJ, Lehmann-Masten V, Otero-Corchon V, Low MJ, Geyer MA (2002) Differential effects of direct and indirect dopamine agonists on prepulse inhibition: a study in D1 and D2 receptor knock-out mice. J neuroscience: official J Soc Neurosci 22(21):9604\u20139611. https:\/\/doi.org\/10.1523\/jneurosci.22-21-09604.2002","journal-title":"J neuroscience: official J Soc Neurosci"},{"issue":"22","key":"3884_CR42","doi-asserted-by":"publisher","first-page":"8485","DOI":"10.1073\/pnas.0402662101","volume":"101","author":"G Tsai","year":"2004","unstructured":"Tsai G, Ralph-Williams RJ, Martina M, Bergeron R, Berger-Sweeney J, Dunham KS, Jiang Z, Caine SB, Coyle JT (2004) Gene knockout of glycine transporter 1: characterization of the behavioral phenotype. Proc Natl Acad Sci USA 101(22):8485\u20138490. https:\/\/doi.org\/10.1073\/pnas.0402662101","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"3884_CR43","first-page":"327","volume":"229","author":"RD Porsolt","year":"1977","unstructured":"Porsolt RD, Bertin A, Jalfre M (1977) Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 229(2):327\u2013336","journal-title":"Arch Int Pharmacodyn Ther"},{"issue":"3","key":"3884_CR44","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s00213-005-0093-5","volume":"182","author":"JF Cryan","year":"2005","unstructured":"Cryan JF, Page ME, Lucki I (2005) Differential behavioral effects of the antidepressants reboxetine, fluoxetine, and moclobemide in a modified forced swim test following chronic treatment. Psychopharmacology 182(3):335\u2013344. https:\/\/doi.org\/10.1007\/s00213-005-0093-5","journal-title":"Psychopharmacology"},{"issue":"2","key":"3884_CR45","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/0091-3057(95)00138-M","volume":"52","author":"RJ Rodgers","year":"1995","unstructured":"Rodgers RJ, Johnson NJ (1995) Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety. Pharmacol Biochem Behav 52(2):297\u2013303","journal-title":"Pharmacol Biochem Behav"},{"issue":"1","key":"3884_CR46","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/0091-3057(95)02126-4","volume":"54","author":"S Hogg","year":"1996","unstructured":"Hogg S (1996) A review of the validity and variability of the elevated plus-maze as an animal model of anxiety. Pharmacol Biochem Behav 54(1):21\u201330","journal-title":"Pharmacol Biochem Behav"},{"key":"3884_CR47","doi-asserted-by":"publisher","first-page":"509","DOI":"10.2147\/ndt.s234371","volume":"16","author":"CH Lin","year":"2020","unstructured":"Lin CH, Yang HT, Chen PK, Wang SH, Lane HY (2020) Precision Medicine of Sodium Benzoate for the treatment of behavioral and psychological symptoms of dementia (BPSD). Neuropsychiatr Dis Treat 16:509\u2013518. https:\/\/doi.org\/10.2147\/ndt.s234371","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"9","key":"3884_CR48","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.1039\/c5fo00549c","volume":"6","author":"YC Hung","year":"2015","unstructured":"Hung YC, Yang HT, Yin MC (2015) Asiatic acid and maslinic acid protected heart via anti-glycative and anti-coagulatory activities in diabetic mice. Food Funct 6(9):2967\u20132974. https:\/\/doi.org\/10.1039\/c5fo00549c","journal-title":"Food Funct"},{"issue":"2","key":"3884_CR49","first-page":"21","volume":"11","author":"GS Mahmoud","year":"2019","unstructured":"Mahmoud GS, Sayed SA, Abdelmawla SN, Amer MA (2019) Positive effects of systemic sodium benzoate and olanzapine treatment on activities of daily life, spatial learning and working memory in ketamine-induced rat model of schizophrenia. Int J Physiol pathophysiology Pharmacol 11(2):21\u201330","journal-title":"Int J Physiol pathophysiology Pharmacol"},{"issue":"5","key":"3884_CR50","doi-asserted-by":"publisher","first-page":"357","DOI":"10.3109\/15622975.2015.1117654","volume":"18","author":"CY Lin","year":"2017","unstructured":"Lin CY, Liang SY, Chang YC, Ting SY, Kao CL, Wu YH, Tsai GE, Lane HY (2017) Adjunctive sarcosine plus benzoate improved cognitive function in chronic schizophrenia patients with constant clinical symptoms: a randomised, double-blind, placebo-controlled trial. world J Biol psychiatry: official J World Federation Soc Biol Psychiatry 18(5):357\u2013368. https:\/\/doi.org\/10.3109\/15622975.2015.1117654","journal-title":"world J Biol psychiatry: official J World Federation Soc Biol Psychiatry"},{"issue":"6","key":"3884_CR51","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.biopsych.2017.12.006","volume":"84","author":"CH Lin","year":"2018","unstructured":"Lin CH, Lin CH, Chang YC, Huang YJ, Chen PW, Yang HT, Lane HY (2018) Sodium Benzoate, a D-Amino acid oxidase inhibitor, added to Clozapine for the treatment of Schizophrenia: a Randomized, Double-Blind, placebo-controlled trial. Biol Psychiatry 84(6):422\u2013432. https:\/\/doi.org\/10.1016\/j.biopsych.2017.12.006","journal-title":"Biol Psychiatry"},{"issue":"12","key":"3884_CR52","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1001\/jamapsychiatry.2013.2159","volume":"70","author":"HY Lane","year":"2013","unstructured":"Lane HY, Lin CH, Green MF, Hellemann G, Huang CC, Chen PW, Tun R, Chang YC, Tsai GE (2013) Add-on treatment of benzoate for schizophrenia: a randomized, double-blind, placebo-controlled trial of D-amino acid oxidase inhibitor. JAMA psychiatry 70(12):1267\u20131275. https:\/\/doi.org\/10.1001\/jamapsychiatry.2013.2159","journal-title":"JAMA psychiatry"},{"issue":"11","key":"3884_CR53","doi-asserted-by":"publisher","first-page":"e2024335","DOI":"10.1001\/jamanetworkopen.2020.24335","volume":"3","author":"JG Scott","year":"2020","unstructured":"Scott JG, Baker A, Lim CCW, Foley S, Dark F, Gordon A, Ward D, Richardson D, Bruxner G, Beckmann KM, Hatherill S, Stathis S, Dixon K, Ryan AE, McWhinney BC, Ungerer JPJ, Berk M, Dean OM, Saha S, McGrath J (2020) Effect of Sodium Benzoate vs Placebo among individuals with early psychosis: a Randomized Clinical Trial. JAMA Netw open 3(11):e2024335. https:\/\/doi.org\/10.1001\/jamanetworkopen.2020.24335","journal-title":"JAMA Netw open"},{"key":"3884_CR54","doi-asserted-by":"publisher","first-page":"3","DOI":"10.2174\/1874104501004020003","volume":"4","author":"SM Smith","year":"2010","unstructured":"Smith SM, Uslaner JM, Hutson PH (2010) The therapeutic potential of D-Amino acid oxidase (DAAO) inhibitors. Open Med Chem J 4:3\u20139. https:\/\/doi.org\/10.2174\/1874104501004020003","journal-title":"Open Med Chem J"},{"issue":"14","key":"3884_CR55","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.2174\/1381612811319140002","volume":"19","author":"S Sacchi","year":"2013","unstructured":"Sacchi S, Rosini E, Pollegioni L, Molla G (2013) D-amino acid oxidase inhibitors as a novel class of drugs for schizophrenia therapy. Curr Pharm Design 19(14):2499\u20132511. https:\/\/doi.org\/10.2174\/1381612811319140002","journal-title":"Curr Pharm Design"},{"issue":"4","key":"3884_CR56","first-page":"205","volume":"41","author":"F Guo","year":"2020","unstructured":"Guo F, Zhang Z, Liang Y, Yang R, Tan Y (2020) Exploring the role and mechanism of sodium benzoate in CUMS-induced depression model of rats. Neuroendocrinol Lett 41(4):205\u2013212","journal-title":"Neuroendocrinol Lett"},{"key":"3884_CR57","doi-asserted-by":"crossref","unstructured":"Lin C-H, Wang S-H, Lane H-Y (2022) Effects of sodium benzoate, a D-amino acid oxidase inhibitor, on perceived stress and cognitive function among patients with late-life depression: a randomized, double-blind, sertraline-and placebo-controlled trial. International Journal of Neuropsychopharmacology","DOI":"10.1093\/ijnp\/pyac006"},{"issue":"3","key":"3884_CR58","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/0304-4165(92)90055-y","volume":"1115","author":"Y Nagata","year":"1992","unstructured":"Nagata Y, Yamamoto K, Shimojo T, Konno R, Yasumura Y, Akino T (1992) The presence of free D-alanine, D-proline and D-serine in mice. Biochim Biophys Acta 1115(3):208\u2013211. https:\/\/doi.org\/10.1016\/0304-4165(92)90055-y","journal-title":"Biochim Biophys Acta"},{"issue":"1\u20132","key":"3884_CR59","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/0304-3940(93)90476-2","volume":"152","author":"A Hashimoto","year":"1993","unstructured":"Hashimoto A, Nishikawa T, Konno R, Niwa A, Yasumura Y, Oka T, Takahashi K (1993) Free D-serine, D-aspartate and D-alanine in central nervous system and serum in mutant mice lacking D-amino acid oxidase. Neurosci Lett 152(1\u20132):33\u201336. https:\/\/doi.org\/10.1016\/0304-3940(93)90476-2","journal-title":"Neurosci Lett"},{"issue":"24","key":"3884_CR60","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1016\/j.jchromb.2009.06.028","volume":"877","author":"Y Miyoshi","year":"2009","unstructured":"Miyoshi Y, Hamase K, Tojo Y, Mita M, Konno R, Zaitsu K (2009) Determination of D-serine and D-alanine in the tissues and physiological fluids of mice with various D-amino-acid oxidase activities using two-dimensional high-performance liquid chromatography with fluorescence detection. J Chromatogr B Anal Technol biomedical life Sci 877(24):2506\u20132512. https:\/\/doi.org\/10.1016\/j.jchromb.2009.06.028","journal-title":"J Chromatogr B Anal Technol biomedical life Sci"},{"issue":"11","key":"3884_CR61","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1124\/dmd.112.046482","volume":"40","author":"R Rais","year":"2012","unstructured":"Rais R, Thomas AG, Wozniak K, Wu Y, Jaaro-Peled H, Sawa A, Strick CA, Engle SJ, Brandon NJ, Rojas C, Slusher BS, Tsukamoto T (2012) Pharmacokinetics of oral D-serine in D-amino acid oxidase knockout mice. Drug Metab Dispos 40(11):2067\u20132073. https:\/\/doi.org\/10.1124\/dmd.112.046482","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"3884_CR62","doi-asserted-by":"publisher","first-page":"e86504","DOI":"10.1371\/journal.pone.0086504","volume":"9","author":"J Sasabe","year":"2014","unstructured":"Sasabe J, Suzuki M, Miyoshi Y, Tojo Y, Okamura C, Ito S, Konno R, Mita M, Hamase K, Aiso S (2014) Ischemic acute kidney injury perturbs homeostasis of serine enantiomers in the body fluid in mice: early detection of renal dysfunction using the ratio of serine enantiomers. PLoS ONE 9(1):e86504. https:\/\/doi.org\/10.1371\/journal.pone.0086504","journal-title":"PLoS ONE"},{"issue":"4","key":"3884_CR63","doi-asserted-by":"publisher","first-page":"586","DOI":"10.3109\/08923973.2011.561861","volume":"33","author":"K Pahan","year":"2011","unstructured":"Pahan K (2011) Immunomodulation of experimental allergic encephalomyelitis by cinnamon metabolite sodium benzoate. Immunopharmacol Immunotoxicol 33(4):586\u2013593. https:\/\/doi.org\/10.3109\/08923973.2011.561861","journal-title":"Immunopharmacol Immunotoxicol"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-023-03884-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11064-023-03884-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-023-03884-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,12]],"date-time":"2023-05-12T07:23:25Z","timestamp":1683876205000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11064-023-03884-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,14]]},"references-count":63,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["3884"],"URL":"https:\/\/doi.org\/10.1007\/s11064-023-03884-1","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,14]]},"assertion":[{"value":"21 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration"}},{"value":"The authors report no declarations of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interest"}}]}}